研究单位：[1]Guangzhou University of Traditional Chinese Medicine[2]Guangdong Provincial Hospital of Traditional Chinese Medicine Guangzhou,Guangdong,China
研究目的：
This is a double-blind, randomized controlled study evaluating the efficacy and safety of HGXJT in combination with ICI-based standard treatment in lung cancer patients with bone metastases. Enrolled participates will randomly receive HGXJT or placebo during the first 4-6 cycles of ICI-based standard treatment.
